Intuitive Surgical, Inc. $ISRG Shares Acquired by World Investment Advisors

World Investment Advisors increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.6% during the 4th quarter, Holdings Channel.com reports. The fund owned 6,888 shares of the medical equipment provider’s stock after buying an additional 1,489 shares during the period. World Investment Advisors’ holdings in Intuitive Surgical were worth $3,901,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Riversedge Advisors LLC boosted its position in shares of Intuitive Surgical by 1.9% in the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock worth $510,000 after acquiring an additional 17 shares during the last quarter. Fiduciary Financial Group LLC boosted its position in shares of Intuitive Surgical by 2.1% in the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock worth $521,000 after acquiring an additional 19 shares during the last quarter. Prosperity Consulting Group LLC boosted its position in shares of Intuitive Surgical by 0.5% in the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after acquiring an additional 19 shares during the last quarter. Sunburst Financial Group LLC boosted its position in shares of Intuitive Surgical by 4.3% in the fourth quarter. Sunburst Financial Group LLC now owns 485 shares of the medical equipment provider’s stock worth $275,000 after acquiring an additional 20 shares during the last quarter. Finally, WoodTrust Financial Corp boosted its position in shares of Intuitive Surgical by 0.5% in the fourth quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock worth $2,367,000 after acquiring an additional 20 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

ISRG has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research report on Tuesday, June 2nd. Raymond James Financial decreased their target price on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a research report on Wednesday, March 11th. The Goldman Sachs Group set a $558.00 price target on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Finally, UBS Group reduced their price target on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 17th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $573.63.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: ISRG was upgraded to a Zacks Rank #2 (Buy), signaling improving earnings expectations and adding a bullish catalyst for the stock.
• Positive Sentiment: Analysts say Intuitive Surgical can use its scale, cost discipline, and growing da Vinci 5 adoption to offset tariff and input-cost pressure, which supports the company’s margin outlook.
• Positive Sentiment: The stock also recently outperformed the broader market, reflecting continued investor confidence in its growth profile. Article: Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts
• Neutral Sentiment: Two executives sold shares under pre-arranged Rule 10b5-1 plans, including EVP Gary Loeb and EVP Mark Brosius. The sales were relatively small and routine, so they may be viewed more as portfolio management than a major red flag.
• Neutral Sentiment: Analyst commentary also noted that ISRG’s fair value estimate was reset lower, which suggests some caution remains despite the company’s long-term growth story.

Insider Activity

In other news, Director Amy L. Ladd sold 119 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total transaction of $55,156.50. Following the sale, the director owned 120 shares in the company, valued at $55,620. This trade represents a 49.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the sale, the executive vice president owned 5,720 shares in the company, valued at $2,426,080.80. This represents a 6.54% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,144 shares of company stock worth $3,048,782 over the last 90 days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Down 3.4%

ISRG opened at $412.02 on Thursday. The firm has a market capitalization of $145.92 billion, a P/E ratio of 49.94, a P/E/G ratio of 3.41 and a beta of 1.46. The firm’s 50 day moving average is $444.91 and its 200-day moving average is $497.84. Intuitive Surgical, Inc. has a 52-week low of $396.68 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The company had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business’s quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.81 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.